Journal of Preventive Medicine and Public Health

  • 제38권4호
  • /
  • Pages.449-456
  • /
  • 2005
  • /
  • 1975-8375(pISSN)
  • /
  • 2233-4521(eISSN)
대한예방의학회 (The Korean Society for Preventive Medicine)
권호 표지

우리나라 미생물 실험실의 생물안전현황

Biosafety of Microbiological Laboratories in Korea

  • 은상준 (서울대학교 의과대학 의료관리학교실) ;
  • 박기동 (질병관리본부 방역과) ;
  • 김종균 (가천의과대학 예방의학교실) ;
  • 임정수 (가천의과대학 예방의학교실) ;
  • 황유성 (네오딘 의학연구소) ;
  • 김용익 (서울대학교 의과대학 의료관리학교실) ;
  • 이진용 (서울대학교 의과대학 의료관리학교실)
  • Eun, Sang-Jun (Department of Health Policy and Management, Seoul National University College of Medicine) ;
  • Park, Ki-Dong (Division of Communicable Disease Control, Korea Center for Disease Control and Prevention) ;
  • Kim, Jong-Kyun (Department of Preventive Medicine, Gachon Medical School) ;
  • Im, Jeong-Soo (Department of Preventive Medicine, Gachon Medical School) ;
  • Hwang, Yoo-Sung (Neodin Medical Institute) ;
  • Kim, Yong-Ik (Department of Health Policy and Management, Seoul National University College of Medicine) ;
  • Lee, Jin-Yong (Department of Health Policy and Management, Seoul National University College of Medicine)
  • 발행 : 2005.12.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives : The biosafety level (BSL) practiced in microbiology laboratories in Korea according to the laboratory biosafety manual published by the World Health Organization (WHO) was evaluated using the data obtained by a survey. Methods : Under the advise of Clinical Laboratory Physicians, 144 types of microorganisms were screened based on the guidelines of biosafety in microbiological and biomedical laboratories published by the US Center for Disease Control and Prevention and classified into 1-4 risk groups. A questionnaire containing 21 questions in 5 areas was developed using the biosafety manual by published WHO. Of the 1,876 different organizations sent the survey, 563 responded to the survey (response rate: 30.0%). The species of microoganisms handled by as well as the biosafety level in microbiology laboratories were analyzed. Results : There were 123 species of microorganisms handled in microbiology labs in Korea. The BSL required in 512 microbiology labs was answered by the survey responders as the first grade in 33 labs (6.4%), 2nd in 437 (85.4%), 3rd in 42 (8.2%), and 4th in none. The average number of items satisfied was 12.2, showing only a 57.9% satisfactory rate and normal distribution. Conclusions : The state of overall observance of BSL in most microbiology labs of Korea was evaluated as lagging compared with the standard set up by WHO. Therefore, the Korean government need to produce and distribute a biosafety manual in microbiology laboratories and make efforts to prevent this threat through measures such as training in biosafety in microbiology labs.

키워드

참고문헌

  1. Wehrle PF. Smallpox eradication. A global appraisal.JAMA 1978; 240(18): 1977-1979 https://doi.org/10.1001/jama.240.18.1977
  2. Minor PD. Biosafety consequences of eradication of wild-type polioviruses. Lancet 2001; 358(9277): 166-168 https://doi.org/10.1016/S0140-6736(01)05399-5
  3. 김용익, 박기동, 임정수, 황유성, 생물테러 가능 병원체와 실험실에 대한 안전등급제 도입 및 운영방안 개발. 국립보권원. 생물 테러대비 두창백신 희석 활용 및 집단예방 접종 방안 개발. 2003
  4. 남명진. 안전관련 법령 제정 방안. 이의경. 생명과학관련 국민보건안전윤리 확보방안. 2000년 보건의료기술개발사업 정책연구개발사업보고서. 보건복지부 2001
  5. Orellana C. Laboratory-acquired SARS raises worries on biosafety. Lancet Infect Dis 2004; 4(2): 64
  6. Kissalt A. Laboratoriums infektionen mit typhusbazillen. Zeit Hyg Infectionkrank 1915; 80: 145-162 https://doi.org/10.1007/BF02175802
  7. Meyer KF, Eddie B. Laboratory infections due to brucella. J Infect Dis 1941; 68: 24-32 https://doi.org/10.1093/infdis/68.1.24
  8. Reid DD. Incidence of tuberculosis among workers in medical laboratories. Br Med J 1957; 2: 10-14 https://doi.org/10.1136/bmj.2.5035.10
  9. Grist NR. Hepatitis in clinical laboratories a three year survey. J Clin Pathol 1975; 28: 255-259 https://doi.org/10.1136/jcp.28.4.255
  10. Grist NR. Hepatitis in clinical laboratories 1973-1974. J Clin Pathol 1976; 29: 480-483 https://doi.org/10.1136/jcp.29.6.480
  11. Grist NR. Hepatitis in clinical laboratories 1975-1976. J Clin Pathol 1978; 31: 415-417 https://doi.org/10.1136/jcp.31.5.415
  12. Richrdson JH. Provisional summary of 109 laboratory-associated infections at the Center for Disease Control, 1947-1973. Presented at the 16th Annual Biosafety Conference, Ames, Iowa. 1973
  13. Martini GA, Schmidt HA. Spermatogenic transmission of Marburg viruus. Klin Wschr 1968; 46: 398-400 https://doi.org/10.1007/BF01734141
  14. Oliphant JW, Parker RR. Q fever: Three cases of laboratory infection. Public Health Rep 1948; 63(42): 1364-1370 https://doi.org/10.2307/4586730
  15. Beeman EA. Q fever-An epidemiological note. Public Health Rep 1950; 65(2): 88-92 https://doi.org/10.2307/4587216
  16. Holmes GP, Hilliard JK, KLontz KC, Rupert AH, Schindler CM, Parrish E, Griffin DG, Ward GS, Bernstein ND, Bean TW, Ball MR, Bready JA, Wilder MH, Kaplan JE. B virus(Herpesvirus simiae) infection in humans: epidemiologic investigation of a cluster. Ann Int Med 1990; 112: 833-839 https://doi.org/10.7326/0003-4819-112-11-833
  17. Her majesty's stationary office. Report of the committee of inquiry into smallpox outbreakin London in march and April 1973. London. 1974
  18. World Health Organization. Smallpox surveillance. Weekly Epidemiol Record 1978; 53(35): 265-266
  19. WHO. Laboratory biosafety mannual. 2nd edition(revised). Geneva. 2003
  20. CDC and NIH. Biosafety in microbiological and biomedical laboratories. 4th edition.Washington. 1999
  21. Advisory Committee on Dangerous Pathogens. Categorization of biological agents accordingto hazard and categories of containment. 4th edition. London. 1995
  22. Office of Laboratory Security. The laboratory biosafety guidelines. 3th edition(draft).Ottawa. 2001
  23. Lee HW, Johnson KM. Laboratory-acquired infections with hantaan virus, the etiologicagent of Korean hemmorrhagic fever. J Infec Dis 1982; 146; 645-651 https://doi.org/10.1093/infdis/146.5.645
  24. Kim JS, Lee HW. Studies on microbiololgical laboratory biosafety (1) a survey on biosafety status in laboratory department of training. Report NIH Korea 1986; 23: 139-160 (Korean)
  25. Cho SH, Ju YS, Kang D, Kim S, Kim IS, Hong ST. Laboratory-acquired infection with hantavirus at a research unit of medical school in Seoul, 1996. Korean J Prev Med 1999; 32(3): 269-275 (Korean)
  26. 보건복지부. 유전자재조합실험지침 보건복지부고시 제1997-22호. 보건복지부; 1996
  27. Sulkin SE, Pike RM. Survey of laboratoryacquired infections. Am J Public Health 1951; 41(7): 769-781 https://doi.org/10.2105/AJPH.41.7.769
  28. Sung WK. Development of the system ensuring biosafety in genetic modification experiment. Health and Welfare Policy Forum 2001; 4: 45-58 (Korean)
  29. 보건복지부. 전염병병원체 검사. 보존 및 관리 지침, 보건복지부 고시 2001-25호. 보건복지부; 2001